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Abstract
Background: Hospitals in European countries apply a wide range of quality improvement strategies. Knowledge of the
effectiveness of these strategies, implemented as part of an overall hospital quality improvement system, is limited.
Methods/Design: We propose to study the relationships among organisational quality improvement systems,
patient empowerment, organisational culture, professionals’ involvement with the quality of hospital care, including
clinical effectiveness, patient safety and patient involvement. We will employ a cross-sectional, multi-level study
design in which patient-level measurements are nested in hospital departments, which are in turn nested in
hospitals in different EU countries. Mixed methods will be used for data collection, measurement and analysis.
Hospital/care pathway level constructs that will be assessed include external pressure, hospital governance, quality
improvement system, patient empowerment in quality improvement, organisational culture and professional
involvement. These constructs will be assessed using questionnaires. Patient-level constructs include clinical
effectiveness, patient safety and patient involvement, and will be assessed using audit of patient records, routine
data and patient surveys. For the assessment of hospital and pathway level constructs we will collect data from
randomly selected hospitals in eight countries. For a sample of hospitals in each country we will carry out
additional data collection at patient-level related to four conditions (stroke, acute myocardial infarction, hip fracture
and delivery). In addition, structural components of quality improvement systems will be assessed using visits by
experienced external assessors. Data analysis will include descriptive statistics and graphical representations and
methods for data reduction, classification techniques and psychometric analysis, before moving to bi-variate and
multivariate analysis. The latter will be conducted at hospital and multilevel. In addition, we will apply sophisticated
methodological elements such as the use of causal diagrams, outcome modelling, double robust estimation and
detailed sensitivity analysis or multiple bias analyses to assess the impact of the various sources of bias.
Discussion: Products of the project will include a catalogue of instruments and tools that can be used to build
departmental or hospital quality and safety programme and an appraisal scheme to assess the maturity of the
quality improvement system for use by hospitals and by purchasers to contract hospitals.
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Background
A substantial amount of research has been carried out in
the last 30 years on assessing and improving the quality
of health care. One of the shifts in focus documented in
this literature is the change from research questions such
as “how can quality be measured?” to “how can quality be
improved?” [1-4]. Despite considerable progress in
answering both questions and the widespread application
of quality strategies (such as accreditation systems, orga-
nisational quality management programmes, audit,
patient safety systems, clinical practice guidelines, perfor-
mance indicators and systems for getting patient views),
quality and safety problems persist and the debate on
how to accelerate and sustain quality improvement is
more relevant than ever [5-9]. In response to this debate
a new research line related to the effectiveness of quality
improvement emerged from the quality field in the last
10 to 15 years. This led to research questions such as
“does quality improvement lead to better quality of
care?”, “which quality tools are most effective?”, “how can
various quality tools be integrated into a context-sensitive
quality and safety improvement programme?” or “what
factors impact on the implementation of quality strate-
gies at hospital level?” [10-13]. These questions are of
high relevance from the perspective of individual health
care professionals and hospitals, which on the one hand
have to comply with existing legislation and statutory
regulation of quality improvement, but on the other hand
have significant sovereignty to select from a range of
quality tools to target organisation-specific quality and
safety problems. Professionals and hospitals alike are
investing a lot of time and energy in quality improvement
efforts, although scientific evaluation of the various
approaches, and thus a systematic effort to enhance
knowledge and learning, is still limited.
Research on assessing the impact of quality
improvement
Within the European Union, a range of research pro-
jects has addressed the evaluation of quality strategies at
hospital level. Among the first was the Concerted
Action Programme on Quality Assurance in Hospitals
(COMAC/HSR/QA), executed between 1990 and 1997
in up to 15 European countries [14]. It identified differ-
ent situational and operational factors at the national,
hospital and topic level, that seemed to influence the
effectiveness of strategies for the implementation of
quality assurance. The EU BIOMED-funded ExPeRT
project, carried out from 1996-1999, aimed at evaluating
the use and development of external peer review models
and to identify where the main models are used in EU
Member States. The project identified four principal
models in use in Europe: ISO, EFQM, peer review and
accreditation, and demonstrated that, in principle, con-
vergence of the four main models in order to gain from
each model’s key strengths is feasible [15-17]. Another
EU project, the ENQuaL network, was set up as a colla-
boration between research experts on quality assessment
and quality management in European countries. The
aim of the network was to facilitate the exchange of
knowledge and expertise among European countries. As
part of the working plan, a questionnaire for the evalua-
tion of quality and safety management in hospitals was
developed [11]. This questionnaire has been used to
compare the amount of quality improvement activities
between countries [18], as well as considering the longi-
tudinal development of quality improvement systems
within one country [19].
The recently EU funded project on Methods of Asses-
sing Response to Quality Improvement Strategies
(MARQuIS) added a new focus to the existing literature.
This project intended to assess the value of different
quality strategies in European hospitals and to provide
the needed information for countries when contracting
care for patients moving across borders. The project
demonstrated substantial variability in the development
of hospitals’ quality improvement systems both within
and between countries. It also indicated that no single
strategy, but rather the combination of quality improve-
ment strategies, was associated with the accomplishment
of favourable hospital outputs. As an exception, external
pressure appeared to be consistently associated with the
implementation of quality improvement strategies at
hospital level [20-24].
The use of surveys of culture and organisation to assess
associations with hospital quality was spearheaded since
the early 1990 s by Shortell and colleagues in the USA
[25-27]. Some of these studies, based on non-randomised
designs, produced tentative evidence of the impact of con-
tinuous quality improvement on clinical practice, which
interacts with physician involvement, individual practi-
tioner’s feedback and supportive organisational culture.
However, randomised studies were not able to demon-
strate this impact on clinical outcomes. Recent work
addressed the impact of organisational quality improve-
ment strategies on hospital patient safety and quality and
supported the proposition that the scope of quality
improvement implementation in hospitals is significantly
associated with hospital-level quality indicators, even
though the directions of the associations are not always
systematically positive [12,13]. The authors concluded that
the successful clinical application of quality improvement
actions depends largely on a supportive regulatory and
competitive environment, its alignment with financial
incentives and with an organisational leadership that is
committed to integrating all aspects of the work.
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More recently, research also addresses evaluation
and impact of hospital accreditation programmes [28].
In a recent systematic review of the accreditation lit-
erature, Greenfield and Braithwaite categorised the
impact of accreditation under ten topics: professions’
attitudes to accreditation, promotion of change, orga-
nisational impact, financial impact, quality measures,
professional development programme assessment,
‘consumer’ views or patient satisfaction, public disclo-
sure, and surveyor issues [7]. They found that, in the
studies included, accreditation was consistently asso-
ciated with promoting change and professional devel-
opment. They also found that the impact on
professions’ attitudes to accreditation, organisational
impact, financial impact, quality measures and pro-
gramme assessment was inconsistent in the literature.
A recent analytical study by the same authors corro-
borated these findings and demonstrated that accredi-
tation predicts leadership and cultural characteristics,
but was not related with organisational climate or
‘consumer’ participation [29].
In summary, the evidence on the factors associated
with the uptake of hospitals of quality improvement, the
impact of quality improvement systems on patient-level
outcomes, and the association of quality improvement
systems with constructs such as professional involve-
ment, patient empowerment and organizational culture,
is limited. These links will be explored further in the
DUQUE research project.
Methods/Design
Overall design
This project builds on the work developed to under-
stand the impact of the implementation of different sys-
tems, such as clinical practice guidelines, and aims to
address their global effects integrated in an organisa-
tional quality improvement system. Given that quality
improvement research is inherently complex, in part
due to its interdisciplinary nature and the ethical, meth-
odological and technical limitations in carrying out
large-scale experimental studies, different levels of orga-
nisational analysis need to be distinguished. Conse-
quently, this project will use mixed methods in data
collection, measurement and analysis. The different
approaches and levels of quality improvement within
the hospital will be conceptualized as follows (Figure 1).
The overall aim of this project is to study to what
extent organisational quality improvement systems,
organisational culture, professional involvement and
patient empowerment are related to the quality of hos-
pital care, assessed in terms of clinical effectiveness,
patient safety and patient involvement in a sample of
European hospitals.
Specific objectives to be pursued are the following:
- 1: To develop a “maturity classification model” for
the assessment of organisational quality improve-
ment systems in EU hospitals.
- 2: To investigate associations between the maturity
of quality improvement systems and measures of
organisational culture, professional involvement and
patient empowerment (at hospital level).
- 3: To investigate associations between the maturity
of quality improvement systems and measures of
clinical effectiveness, patient safety and patient invol-
vement (at patient and departmental level).
- 4: To identify factors influencing the uptake of
quality improvement activities by hospitals, including
external pressure as enforced by accreditation, certi-
fication or external assessment programmes.
Data will be collected cross-sectionally at hospital, care
pathway, professional and patient level. We will employ a
multi-level study design in which patient-level measure-
ments are nested in hospital departments, which are in
turn nested in hospitals in different EU countries. The
objectives of the project and the different constructs
(explained below) that will be assessed within the
DUQuE project can be illustrated as follows (Figure 2).
Setting and sampling
We will collect data in eight countries with a mix of
health and hospital system financing and organisation in
different geographical areas in Europe. Recruitment
among hospitals will be made in each country randomly
using criteria defined by the scientific group. Random
lists of hospitals will be drawn to compose both the
sample of initial hospitals and of substitute hospitals. If
a hospital in the initial sample declines the invitation to
participate, substitute hospitals will be added, based on
the organisational sampling criteria (ownership, type of
hospitals) in order to maintain the representativeness of
the sample at country level.
Hospital-wide constructs will be assessed among the
selected hospitals in each of the eight participating
countries. In each country, for a sub-sample of these
hospitals we will carry out additional data collection at
the patient-level. Patient-level data will be collected for
four conditions, namely stroke, acute myocardial infarc-
tion, hip fracture and child delivery. These conditions
were chosen based on the following criteria: high finan-
cial volume, high prevalence of the condition, existence
of validated measures for its assessment, high variability
of process and outcomes in the literature, and coverage
of different types of patients and specialists. For each
condition, randomly selected patient records will be
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reviewed. Given the multi-level design of the project, the
number of patient records to be reviewed is substantially
lower than in a traditional design. Power calculations
were performed and will be refined, once the measures
have been selected, to determine the discriminatory
power of the measures.
Measure development
Hospital and pathway level measures
For this project, wherever possible, existing instruments
will be used rather than developing new measures. Gen-
eral criteria for selection of measures are the following:
scientific properties (e.g. validity, reliability, association
with outcomes, and sensitivity to change), applicability to
international comparative research, and susceptibility to
bias and degree of technical expertise/support required
to complete the instrument. For the assessment of the
quality improvement system, the project will draw on the
previous experience of the MARQuIS and ENQUAL
instruments to assess hospital quality improvement sys-
tems [23,11]. Professional involvement will be assessed
using a new instrument based on current work in the
field [30-33]. Organisational culture will be assessed
using existing measures, the selection of which will be
informed by a recent and comprehensive review of mea-
sures [34]. Patient empowerment, understood as patients’
contributions to quality management through which they
are able to express their needs, present their concerns,
devise strategies for involvement in decision-making and
achieve political, social and cultural action to meet those
needs, will be based on research previously performed in
the MARQuIS and ENQuAL projects. Hospital govern-
ance and external pressure will be assessed using existing
classifications [35,36,24].
Patient level measures
Patient level measures include clinical effectiveness,
patient safety and patient involvement. We conceptualize
measures of clinical effectiveness in two ways: firstly, to
address care provision in line with evidence-base stan-
dards, and, secondly, to address outcomes of care [37].
For patient safety measures we refer to any measure that
potentially prevents harm caused by errors of commis-
sion or omission [38]. In order to improve relevance to
quality improvement and to comply with the criteria
Figure 1 Conceptualization of quality improvement at hospital, pathway and patient level
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implicit in the definitions of clinical-practice guidelines,
measures of clinical effectiveness and patient safety will
be initially assessed in relation to discrete patient charac-
teristics. Measures of clinical effectiveness and patient
safety will be retrieved through audit of patient records,
which is a common approach in epidemiological
research, quality assessment and improvement and clini-
cal research. Previous work on comparisons of coding,
documentation and completeness of patient records in
European countries will guide the logistics of record
audit [39]. With regard to data extraction formulae, sub-
stantial work has been done on developing quality mea-
sures in Denmark, the USA and other countries and we
will draw on existing work in order to refine and standar-
dise hospital data, data transmission and performance
measures in order to construct one robust, prioritised
and standard quality measure set for hospitals. The need
for risk-adjustment will be assessed on the basis of the
final measures selected, and whether they are process or
outcome measures.
Patient involvement is understood as the extent to
which patients participate in decisions related to their
condition (through informed consent, therapy plan or
self-management) and contribute to organisational
learning through their expert knowledge acquired dur-
ing illness and hospitalisation [40,41]. Patient involve-
ment will be assessed using a combination of existing
patient surveys, drawing on existing measures of
patient-centredness, shared-decision making and
discharge preparation [42-46]. Instruments will be
assessed for suitability (domain mapping) and discrimi-
natory power. Measures will then undergo a process of
backward and forward translation and cognitive testing.
Psychometric analysis will address cultural differences
and operational equivalence across countries [47].
In addition, we will collect administrative data for
selected indicators. Since these data are readily available,
are inexpensive to acquire, are computer readable and
typically encompass large populations, they will be used
for additional evaluation and validation studies. Concre-
tely, we will collect disease-specific mortality rates (for
acute myocardial infarction and stroke) and data on
generic patient safety issues. These measures will be
used for validation studies of the classification instru-
ment for quality improvement systems. Additional work
will address the potential for using administrative
Figure 2 Conceptual model for the multi-level DUQuE study: constructs and hypothesized relationships
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databases for quality improvement activities in the
future [48].
Data analysis
We envisage a series of statistical analyses with two
main aims: (i) to validate the project constructs and (ii)
to provide results for the four core objectives of the
project. To address these two analytical aims, we will
conduct any of four types of statistical analyses where
appropriate: (a) descriptive, (b) data reduction and clas-
sification, (c) bivariate, and (d) multivariate analyses.
Descriptive statistics and graphical representations will
be used to summarize the central tendencies, spread,
frequencies or distributions of all relevant variables. Data
reduction, classification techniques and psychometric
methods will be employed to investigate the psychometric
properties of questionnaires and other instruments used in
measuring constructs relevant to the project such as orga-
nisational culture, professional involvement, and patient
involvement. Before embarking on multivariate analyses,
the project will conduct a series of bivariate analyses. As a
prelude to the multivariate models, unadjusted regressions
linking the relevant explanatory variables to their out-
comes will also represent a type of bivariate analysis. The
multivariate analyses will be conducted on two levels: hos-
pital-level and multilevel. The hospital-level multivariate
analysis specifies both explanatory variables and outcomes
at the hospital-level. All analyses will adjust for relevant
covariates as determined within the analytical framework,
guided by background knowledge and theory [49]. The
multilevel multivariate analysis refers to regression analysis
of patient outcomes nested within hospitals, with adjust-
ment for both patient-level and hospital-level covariates
[50]. The multivariate regressions are by far the most
important analyses needed for providing answers to the
project’s research objectives. The techniques of policy ana-
lysis [51,52] will be applied to the fourth research objec-
tive–identifying external factors influencing uptake of
quality improvement activities.
We will introduce and apply a few sophisticated meth-
odological elements which will be innovative for the field
of performance and quality of care research. These inno-
vative elements will constitute significant progress for
health services research because they represent recent
methodological advances from biostatistics, epidemiolo-
gic methodology, causality in artificial intelligence, and
philosophy of science [53,54]. The first innovative
element involves using directed acyclic graphs or causal
diagrams to guide the specification of the abovemen-
tioned multivariate regressions which translate the analy-
tical framework of the project [55]. The second
innovative element involves extending the foregoing
regressions which directly model the outcomes under
study to modelling the explanatory variable (or exposure)
as well, and then using the modeled version of the expo-
sure to analyse the outcome in a second step [56]. The
third innovative element is that we will further extend
the outcome regression and exposure modeling by com-
bining the two modeling approaches in the so-called dou-
bly robust estimation [57,58]. Finally, given the wide
variety of variables being conceptualised and measured in
this project, we will conduct detailed sensitivity analysis
or multiple bias analysis to assess the impact of the
various sources of bias such as measurement error, (non-
)response, uncontrolled confounding, and missing data
on our results [59-61]. Missing data will be imputed
using multiple imputation techniques [62]. All core ana-
lyses will be conducted with and without imputation for
individual variables, including variables that will be
imputed at the level measurement, that is, before aggre-
gation to form hospital-level measures. The richer infor-
mation contained in the multilevel datasets is expected to
improve the multiple imputations.
Analysis of policy implications
Based on the data analysis an appraisal scheme will be
developed to guide hospitals in developing their quality
improvement systems and to inform purchasers about
the most effective quality improvement mechanisms.
These appraisal schemes will differ in presentation, level
of detail and focus. Their design will follow recent
research on the development of tools to guide evidence-
informed health policy making [63,64]. The guidance
document for hospitals provides a more in-depth over-
view of the effectiveness of quality and safety strategies
and how to integrate them at hospital and departmental
level. The guidance document for commissioners/
purchasers will aim at synthesising the main messages
and identifying the core quality and safety strategies that
should be in place at hospital and department level. It is
expected that such criteria would be of use in subse-
quent contracting of hospital services.
Ethics and confidentially issues
The project has been granted financial support and ethi-
cal approval from the European Commission. In addi-
tion, the ethics unit from the Department of Health in
Catalonia, Spain, where the project lead is based, has
confirmed the DUQuE project can be characterised as
clinical audit (in contrast to human research) and as
such does not require further ethical approval by the
Catalan Ethical Committee for Clinical Research beyond
that already granted by the European Commission in
reviewing and approving the enclosed description of
work.
This assessment is based on the distinction between
clinical audit and human research introduced by the
Council of Europe Draft Guide for Research Ethics
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Committee Members [65], according to which clinical
audit is characterized by: a) the purpose of improving
the quality of patient care in the local setting; b) mea-
suring practice against standards; and c) doing nothing
to patients which would not be part of routine practice.
Other ethical committees have passed similar evalua-
tions for research that is based on common quality
improvement methods and that does not interfere with
patient care in any way [66].
The project has developed strict privacy and confiden-
tiality criteria for sampling of hospitals, professionals
and patients, and for data collection, processing, analysis
and reporting. These procedures are described in the
project proposal approved by the European Commission
and in complementary internal documents that specify
information flow and technological issues around data
processing.
Investigators
The research team comprises experienced clinical, orga-
nisational and social science researchers, with experi-
ence in health services research, quality improvement
research, organisational behaviour, survey design, statis-
tical modelling, accreditation research, indicator devel-
opment, external evaluation and clinical practice. Most
researchers have previously been extensively involved in
cross-national comparative quality improvement and
health services research. Moreover, the researchers are
affiliated with some of the main organisations driving
quality improvement research in their respective coun-
tries and in Europe. In addition, the key research team
will draw on the knowledge of a number of experts in
dedicated content areas.
Discussion
The results of the research should be relevant to multi-
ple stakeholders, such as the European Commission and
member states, healthcare institutions (hospitals and
purchasing agencies). The results are also expected to
contribute to advances in to methodological quality
improvement research.
Policy impact
At the policy level, as summarised in the previous sec-
tion, considerable advances have been made in assessing
quality improvement systems in the last years. However,
an important question remains: what is the effect of
quality improvement strategies and which combination
of strategies work best? The objective of this project fol-
lows this question and aims at expanding previous
research, taking into account the contextual variables of
hospitals and patients’ pathways at departmental level.
This research would then be able to give guidance on a
comprehensive set of strategies demonstrated to be
effective whilst being sensitive to the context/country of
a hospital. Having the unique advantage of basing
DUQUE on leading existing research and the most
recent contributions to the field, the following advances
to the existing research literature will be made. Firstly,
several innovative research projects are underway inter-
nationally, in particular in the USA and in Australia.
We will link to these leading initiatives and apply the
latest methods to European hospitals. Secondly, we are
collaborating with existing international efforts to
develop and validate performance indicators on quality
and safety in health care. Thirdly, the results of several
previous EU-funded projects are at this stage concep-
tually and empirically outdated [14,15,11]. We will
advance existing work both conceptually, by exploring
links between external pressure, quality systems and
patient-level outcomes, and by collecting up-to-date
data from a large sample of European hospitals.
Fourthly, the MARQuIS project contributed to the
research agenda by exploring the impact of hospital
quality improvement systems on the uptake of specific
quality and patient safety initiatives at the departmental
level. DUQuE will further enhance, refine and systema-
tise the various components (quality strategies and qual-
ity improvement systems) and will establish the nature
of the relationship with process and outcome measures
at patient level. Fifthly, the project is of high relevance
in the context of the recent proposal for an EU directive
on the application of patients’ rights to cross-border
health care [67]. Given that it is impossible to predict
which hospitals will provide cross-border care in the
future, all hospitals need to make sure that the appro-
priate quality and safety mechanisms are in place
[68,69]. The DUQUE research project addresses this
policy issue.
Scientific contributions and methodological innovations
The proposed research project also makes distinctive
contributions to improving quality and safety of care in
the EU using an empirical approach. From a methodolo-
gical perspective, the scientific contributions of the pro-
ject are three-fold. Firstly, we will advance the validation
of a number of relevant constructs relevant to advancing
quality improvement systems in European hospitals. For
example, we will select, adapt and build measures of
organisational culture, professional involvement and
patient empowerment, which in themselves can be used
in further studies at national or European level. Sec-
ondly, by adding these measures to the organisational
assessment, we will make relevant scientific contribu-
tions to understanding the interactions between these
constructs and the hospitals’ quality improvement
systems. Thirdly, by including measures of external
pressure and hospital governance on the one hand, and
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using patient-level outcome data on the other, we will
be able to establish associations that exist between con-
structs that will result in our appraisal scheme for qual-
ity improvement systems. For the analysis of the large
scale database we will include a number of methodologi-
cal innovations described above.
Conclusion
Research on quality in health care has over the last 30
years resulted in a substantial increase in knowledge of
the measurement of quality, on variations in health care
delivery, on the implementation of clinical practice
guidelines based on best-evidence, on assessing patient
satisfaction and experience and, more recently, on esti-
mating the incidence of adverse events, which led to the
patient safety movement. For several of these issues and
based on scientific evidence, consensus exists, which has
been summarised in appraisal schemes that facilitate
synthesis of information, development of new tools and
their application. Nevertheless, evidence of the effective-
ness of organisational quality improvement systems has
only more recently been accumulated. The DUQuE
Research Project builds on the work developed to
understand the impact of the implementation of differ-
ent systems and aims to address their global effects
through integration within an organisational quality
improvement system.
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